OpGen, Inc. Profile Avatar - Palmy Investing

OpGen, Inc.

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for t…

Medical - Diagnostics & Research
US, Rockville [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

OpGen, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

OpGen, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of OpGen, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of OPGN's Analysis
CIK: 1293818 CUSIP: 68373L307 ISIN: US68373L4068 LEI: - UEI: -
Secondary Listings
OPGN has no secondary listings inside our databases.